Free Access to TSR Screeners - Sign Up for Your Weekend Pass
Birds's Eye
Technicals
MovingAverage
Candlestick
PivotPoint
Fin Statements
Beta&Vols
Tech Charts
Future/OptionFundamental Analysis of Divi's Laboratories Ltd. - Growth / Value Index
DIVISLAB - Valuation Highlights
Valuation Analysis
Book Value in last 3 years is trending up
Tsr Value Index - Very Poor Score of 13.89
Expensive - Price to Intrinsic Value of 2.62
Price to Earning Ratio is 67.28 and EV to EBITDA is 44.36 suggesting that it is very expensive
Price to Book Ratio of 11.20 suggesting that it is very expensive
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Price to Earning | 66.59 | 69.98 | 22.42 % | ||
| Price to Book | 11.08 | 10.24 | 51.98 % | 10.71 | |
| Price to Sales | 16.00 | 16.38 | 40.50 % | ||
| Enterprise Value to EBITDA Multiple | 46.06 | 33.94 % |
DIVISLAB - Profitability Highlights
Profitability Analysis
Excellent Net Margin for last 3 years
Company Earning excess return
All key Trailing Twelve Months Margin growing by 15 %
Piotroski F Score - Stable Value of 5.0
Good Return On Capital Employed of 14.63
Good Return on Equity of 16.64% is achieved by the company
Good Net Margin of 24.04% is achieved by the company
Very Low Dividend Yield of 0 %
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|---|
| Return On Equity | 16.64 | 14.64 | 24.15 % | 3.78 | |
| Return On Asset | 14.45 | 12.94 | 25.11 % | 3.21 | |
| Net Profit Margin | 24.04 | 23.41 | 14.77 % | 22.39 | |
| Operating Profit Margin | 32.90 | 27.39 | 17.82 % | 34.18 | |
| EBITDA Margin | 36.43 | 35.47 | 9.38 % | 34.72 |
Highlights
| Market Cap | 1653.60 B |
| Enterprise Value | 1649.47 B |
| Price/Book TTM | 11.08 |
| Outstanding Share | 265468 K |
| Float/ Outstanding Share | 44.34% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 5.72 |
| Peter Lynch Ratio | 0.555 |
| Piotroski F Score | 5.00 |
| Altman Z Score | 53.50 |
| Sloan Ratio | 0.079 |
| Peter Lynch Fair Value | 985.76 |
DIVISLAB - Growth Highlights
Growth Analysis
Annual sales of the company is increased for three years in a row
Steady increase in Total Assets for last 3 Years
Tsr Growth Index - Very Poor Score of 16.15
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 10314.00 (Cr) | 19.31 % | 4.09 % |
| Gross Profit | 5892.00 (Cr) | 73.71 % | 41.19 % |
| EBITDA | 3757.00 (Cr) | 30.50 % | 12.49 % |
| Net Profit | 2479.00 (Cr) | 36.94 % | 15.38 % |
| EPS | 93.55 | 36.93 % | NA |
DIVISLAB - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 95.00
Altman Z Score of 54.02 suggests good Stability
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
|---|---|---|---|---|
| Debt to Equity Ratio | 0.0001 | 81.32 % | 0.0058 | |
| Cash Ratio | 2.56 | -17.84 % | ||
| Quick Ratio | 4.71 | -7.18 % | 3.71 | |
| Shareholders Equity | 88.41 | 0.777 % | ||
| Debt to EBITDA | 0.0006 | 53.25 % |
Historical Valuation Ratios of Divi's Laboratories Ltd.
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Divi's Laboratories Ltd.
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Divi's Laboratories Ltd.
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Divi's Laboratories Ltd.
Historical Solvency Ratios
Loading ...